Zhejiang Hisoar Pharmaceutical Co., Ltd.
002099.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.23B
Close$
$-0.57
109.8% downside
Current Fair Value
109.8% downsideOvervalued by 109.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.23 Billion |
|---|---|
| Enterprise Value | $10.50 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 0.36 |
| Outstanding Shares | 1,879,608,786 |
Return
| Return on Equity | -3.53% |
|---|---|
| Return on Assets | -2.37% |
| Return on Invested Capital | -2.05% |
Valuation & Multiples
| P/E Ratio | -158.79 |
|---|---|
| PEG | 8.1 |
| Price to Sales | 5.8 |
| Price to Book Ratio | 2.9 |
| Enterprise Value to Revenue | 5.36 |
| Enterprise Value to EBIT | -105.01 |
| Enterprise Value to Net Income | -63 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Hisoar Pharmaceutical Co., Ltd.
2,736 employees
CEO: Guorui Xu Zhejiang Hisoar Pharmaceutical Co., Ltd. is a pharmaceutical enterprise that specializes in the manufacturing and global distribution of fine chemicals and specialized active pharmaceutical ingredients (APIs). Its diverse product portfol...